Assuntos
Amiloide/biossíntese , Amiloidose , Enteropatias , Mucosa Intestinal/metabolismo , Amiloide/efeitos dos fármacos , Amiloidose/diagnóstico , Amiloidose/tratamento farmacológico , Amiloidose/etiologia , Colchicina/uso terapêutico , Diagnóstico Diferencial , Supressores da Gota/uso terapêutico , Humanos , Enteropatias/diagnóstico , Enteropatias/tratamento farmacológico , Enteropatias/etiologia , Intestinos/patologia , PrognósticoRESUMO
The combination of the eosinophilic infiltration of the stomach, small and large intestine with psoriasis is described. Diarrhea and syndrome of the disturbed absorption in eosinophilic gastroenteritis coincided with exacerbation of the skin disease. Clinical regression of both conditions with disappearance of peripheral eosinophilia occurred simultaneously. Participation of T-cell immunity and IgE is suggested as a pathogenetic mechanism of eosinophilic gastroenteritis and psoriasis.
Assuntos
Eosinofilia/patologia , Gastroenterite/patologia , Intestino Grosso/patologia , Intestino Delgado/patologia , Psoríase/patologia , Eosinofilia/etiologia , Gastroenterite/etiologia , Humanos , Síndromes de Malabsorção/etiologia , Síndromes de Malabsorção/patologia , Masculino , Pessoa de Meia-Idade , Psoríase/complicaçõesRESUMO
Mucosal repair in the stomach and duodenum was assessed clinically and morphologically in various ulcer phases in 475 patients with gastroduodenal ulcer. It was found that poorly scarring ulcers are characterized by severe impairment of regeneration with epithelial proliferation prevailing over its differentiation. Participation of immune system, primarily T-cell component, in regeneration regulation is shown. Helicobacter pylori is not involved in repair. Superoxide dismutase activity in red cells and ulcer edges mucosa is prognostically significant indicating the disease phase, completeness of ulcer process.
Assuntos
Duodeno/patologia , Mucosa Gástrica/patologia , Úlcera Péptica/patologia , Adulto , Duodeno/cirurgia , Endoscopia do Sistema Digestório , Feminino , Mucosa Gástrica/metabolismo , Mucosa Gástrica/cirurgia , Humanos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patologia , Mucosa Intestinal/cirurgia , Peroxidação de Lipídeos/fisiologia , Masculino , Pessoa de Meia-Idade , Úlcera Péptica/metabolismo , Úlcera Péptica/cirurgia , Superóxido Dismutase/metabolismo , Linfócitos T/patologiaAssuntos
Enteropatias/epidemiologia , Gastropatias/epidemiologia , Tuberculose Gastrointestinal , Antituberculosos/uso terapêutico , Endoscopia Gastrointestinal , Humanos , Enteropatias/diagnóstico , Enteropatias/tratamento farmacológico , Morbidade/tendências , Federação Russa/epidemiologia , Gastropatias/diagnóstico , Gastropatias/tratamento farmacológico , Tuberculose Gastrointestinal/diagnóstico , Tuberculose Gastrointestinal/tratamento farmacológico , Tuberculose Gastrointestinal/epidemiologiaAssuntos
Antiácidos/uso terapêutico , Antibacterianos/uso terapêutico , Antiulcerosos/uso terapêutico , Bismuto/uso terapêutico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori , Compostos Organometálicos/uso terapêutico , Úlcera Péptica/tratamento farmacológico , Úlcera Duodenal/tratamento farmacológico , Duodenite/tratamento farmacológico , Estudos de Avaliação como Assunto , Gastrite/tratamento farmacológico , Refluxo Gastroesofágico/tratamento farmacológico , Humanos , Úlcera Gástrica/tratamento farmacológico , Fatores de TempoRESUMO
475 patients with stomach ulcer (1984-1993) were studied using various methods: endoscopical, immunological, biochemical, bacteriological and morphological. Morphology of exacerbation and type of reparative processes in normal scarring and torpid course of disease are presented. Under adequate regeneration there is an activation of immune system, first that of T-cell compartment. Torpid course is characterized by a grave regeneration disturbance and depression of the immune system. The interpretation of the so-called "red scar" is given: it reflects different stages of the epithelial regeneration, however in 4.8% of duodenal ulcers and in 11.2% of stomach ulcers it masks a torpid course. Helicobacter pylori has no influence on the reparative processes. Adequately chosen therapy improves and accelerates ulcer scarring.
Assuntos
Úlcera Duodenal/patologia , Regeneração/fisiologia , Úlcera Gástrica/patologia , Adulto , Diferenciação Celular , Divisão Celular , Úlcera Duodenal/imunologia , Úlcera Duodenal/fisiopatologia , Endoscopia do Sistema Digestório , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Úlcera Gástrica/imunologia , Úlcera Gástrica/fisiopatologiaRESUMO
Helicobacter pylori (HP) in 41 patients (10 with stomach ulcer and 31 with duodenum ulcer) was found in gastro-biopsies from the stomach antrum before and after the treatment. The following methods to reveal HP were used: Giemsa staining, immunoperoxidase reaction with polyclonal monospecific antibodies against HP, urease rapid test. HP was also revealed in the blood serum by antibodies against HP by means of enzyme immunoassay. Electron microscopy was performed in 5 patients and bacteriologic study in 10 patients. Immunohistochemical method allows one to judge about real HP colonization of the gastric mucosa. Bacterioscopy with Giemsa staining gives good results but they are not true markers of HP presence this being explained by other methods. Serologic enzyme immunoassay gives an idea about the patient contamination, but not about HP eliminations as a result of treatment. Urease-test is adjuvant.
Assuntos
Úlcera Duodenal/microbiologia , Infecções por Helicobacter/diagnóstico , Helicobacter pylori/isolamento & purificação , Úlcera Gástrica/microbiologia , Corantes Azur , Técnicas Bacteriológicas , Biópsia , Humanos , Técnicas Imunoenzimáticas , Antro Pilórico/microbiologia , UreaseAssuntos
Úlcera Péptica/terapia , Antagonistas Adrenérgicos beta/administração & dosagem , Antiácidos/administração & dosagem , Antiulcerosos/administração & dosagem , Terapia Combinada , Avaliação de Medicamentos , Antagonistas dos Receptores H2 da Histamina/administração & dosagem , Hospitalização , Humanos , Modalidades de Fisioterapia/métodos , Recidiva , Cicatrização/efeitos dos fármacos , Cicatrização/fisiologiaAssuntos
Linfócitos B/imunologia , Úlcera Duodenal/imunologia , Úlcera Gástrica/imunologia , Linfócitos T/imunologia , Úlcera Duodenal/terapia , Duodeno/imunologia , Mucosa Gástrica/imunologia , Humanos , Mucosa Intestinal/imunologia , Contagem de Leucócitos , Úlcera Gástrica/terapia , Cicatrização/imunologiaAssuntos
Tecido Conjuntivo/fisiologia , Linfócitos/fisiologia , Macrófagos/fisiologia , Regeneração/fisiologia , Comunicação Celular/fisiologia , Divisão Celular/fisiologia , Células do Tecido Conjuntivo , Humanos , Linfócitos/citologia , Linfócitos/imunologia , Macrófagos/citologia , Macrófagos/imunologiaRESUMO
The analysis of the literature, the material, and the results of the authors' own studies concerning the comprehensive investigation of blockers of histamine H2-receptors are presented. The attention is paid to the reparative action of drugs of this group, side effects, interaction with other drugs. The limitations and possibilities of their use in various diseases proceeding with gastric hypersecretion and hyperchlorhydria are determined.
Assuntos
Antagonistas dos Receptores H2 da Histamina/uso terapêutico , Medicina Interna , Avaliação de Medicamentos , Antagonistas dos Receptores H2 da Histamina/efeitos adversos , Antagonistas dos Receptores H2 da Histamina/farmacologia , HumanosAssuntos
Antagonistas dos Receptores H2 da Histamina/uso terapêutico , Úlcera Péptica/tratamento farmacológico , Ácido Gástrico/metabolismo , Antagonistas dos Receptores H2 da Histamina/síntese química , Antagonistas dos Receptores H2 da Histamina/farmacocinética , Humanos , Úlcera Péptica/metabolismo , Úlcera Péptica/fisiopatologiaAssuntos
Ácido Gástrico/metabolismo , Antagonistas dos Receptores H2 da Histamina/uso terapêutico , Úlcera Péptica/tratamento farmacológico , Ranitidina/farmacologia , Cimetidina/efeitos adversos , Cimetidina/farmacologia , Famotidina/farmacologia , Famotidina/uso terapêutico , Humanos , Úlcera Péptica/fisiopatologia , Ranitidina/uso terapêuticoRESUMO
The description is given of Shwachman syndrome in a male of 17, with a long anamnesis of malabsorption syndrome, granulocytopenia, repeated bronchopneumonia, somatogenic subnanism and hypogonadism. The death resulted from acute cardiovascular insufficiency. Post-mortem examination revealed exocrine pancreas hypoplasia with lipomatosis, Wirsung duct atresia, fibrocholangiocytosis and fat hepatosis, visceral anemia, delay in the maturation of granulocytes in the bone marrow, somatogenic polyglandular endocrinopathy, metabolic myocardium necrosis, calcinosis of the small arteries wall, lymphoid tissue atrophy, focal pneumonia of the upper lobe of the left lung.
Assuntos
Doenças da Medula Óssea/patologia , Lipomatose/patologia , Pâncreas/anormalidades , Adolescente , Doenças Cardiovasculares/patologia , Humanos , Masculino , SíndromeRESUMO
The paper deals with reparative potential of gastric and duodenal mucosa in ulcer in connection with the presence and quantity of Campylobacter pylori (CP) which is found practically in all patients not only with duodenal localization of ulcer but with mediogastric and pyloroantral localization as well. No correlation between the CP presence and CP mucosa colonization on the one hand and the type of reparative processes in the mucosa is found. The presence or the absence of CP as well as the degree of CP mucosal dissemination have no influence on the clinical course of the ulcer. Antiulcer treatment aiming at aggression factors (histamine H2-receptors blockers) and protective factors (enprostil) and lacking antibacterial activity improves the reparative processes but does not influence CP. Thus, CP is not etiological and probably is not a main pathogenetic factor in ulcer development. Its participation in the genesis of ulcer is possibly brought about under conditions of suppression of local protective mechanisms.